Par Pharmaceutical

Acquired

Par Pharmaceutical is a healthcare company in Woodcliff Lake, United States, founded in 1978. It has raised $1.9B across 1 round, most recently a $1.9B Private Equity in July 2012.

Elevating the Essentials™

Employees
1001–5000
Founded
1978
Business Model
B2B
Total Funding
$1.9B
Last Round
$1.9B Private EquityJul 2012
Rounds
1
Acquisition Date
May 2015

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

Par Pharmaceutical (now operating as Par Health following its 2015 acquisition by Endo International) is a specialty pharmaceutical company focusing on the development, licensing, manufacturing, and marketing of generic and branded pharmaceutical products. The company specializes in oral solid dosage forms and injectables, serving healthcare providers and pharmaceutical distributors across the United States.

Summary

It lists 1001–5000 employees. It has raised $1.9B in total across 1 round, most recently a $1.9B Private Equity round in Jul 2012. Investors include Endo International and TPG (Growth/Rise).

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
AcquisitionMay 2015

Sign up to see all 2 events

Funding: Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Par Pharmaceutical on Indexed.vc
<a href="https://indexed.vc/companies/par-pharmaceutical"><img src="https://indexed.vc/api/badge/company/par-pharmaceutical" alt="Par Pharmaceutical on Indexed.vc" width="260" height="76" /></a>